TY - JOUR
KW - buprenorphine
KW - Long-acting injectables
KW - opioid use disorder
KW - treatment
AU - M. R. Lofwall
AU - L. C. Fanucchi
A1 - 
AD - University of Kentucky College of Medicine, Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, 845 Angliana Avenue, Lexington, KY 40508, United States of America. Electronic address: michelle.lofwall@uky.edu.; University of Kentucky College of Medicine, Department of Internal Medicine, Division of Infectious Disease, Center on Drug and Alcohol Research, 845 Angliana Avenue, Lexington, KY 40508, United States of America.
BT - Preventive medicine
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - United States
DO - 10.1016/j.ypmed.2021.106756
JF - Preventive medicine
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 1096-0260; 0091-7435
SP - 106756
T1 - Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
T2 - Preventive medicine
TI - Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34352306
U3 - 10.1016/j.ypmed.2021.106756
VO - 1096-0260; 0091-7435
Y1 - 2021
Y2 - Aug 2
ER -